|
主題：
|
Towards developing the next generation of clinical care for Alzheimer's Disease : Role of the Memory Aging and Cognition Centre in Singapore
The recent advances in defining Alzheimer’s disease (AD) as a biological as well as a clinical construct has aided the development of biomarker-guided, pathophysiology-based targeted therapies, many of which have reached late-stage development with the near-term potential to enter clinical practice. This paradigm shift requires an optimized global framework for clinical care pathways for AD. In this lecture, we describe a recently published blueprint for transitioning from the current, clinical symptom-focused and inherently late-stage diagnosis and management of AD to a next-generation pathway that incorporates biomarker-guided and digitally facilitated decision-making algorithms for risk stratification, early detection, timely diagnosis, and preventative or therapeutic interventions. We describe how the Memory Aging and Cognition Center in Singapore hopes to address this critical and high-priority challenges, describe some evidence-based strategic solutions, and emphasize how the perspectives of affected individuals and care partners in the community need to be considered and integrated.
>>More Information
|
|
時間：
|
Oct 21, 2022, 12:30~13:30 (會議室串流將於中午12:20開啟)
12:30~12:35 Opening (online meeting room open at 12:20 p.m.)
12:35~13:15 Towards developing the next generation of clinical care for Alzheimer's Disease : Role of the Memory Aging and Cognition Centre in Singapore
13:15~13:30 Q&A
|